A Study to Compare Two Formulations of Xylometazoline/Dexpanthenol Nasal Spray for the Treatment of Nasal Congestion.

PHASE3CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

February 26, 2018

Primary Completion Date

May 2, 2018

Study Completion Date

May 2, 2018

Conditions
Nasal Congestion
Interventions
DRUG

xylo+dex nasal spray (0.1 mg+5 mg/dose)

Xylometazoline+Dexpanthenol metered nasal spray (0.1 mg+5 mg/dose) for nasal congestion. One spray into each nostril, 3 times daily for max 5 days.

DRUG

Nasic

Xylometazoline+Dexpanthenol metered nasal spray (0.1 mg+5 mg/dose) for nasal congestion. One spray into each nostril, 3 times daily for max 5 days.

Trial Locations (5)

109386

"Railways clinical hospital n.a.Semashko at Lublino station JSC RZD", Moscow

117556

City Polyclinic #2, Moscow

119991

First Moscow State Medical University n. a. I. M. Sechenov, Moscow

196143

"Scientific and Research centre Eco-safety Limited Liability Company", Saint Petersburg

197022

The First St. Petersburg state medical University n.a. Acad. I. P. Pavlov, Saint Petersburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

McNeil AB

INDUSTRY